In this week’s View, Dr. Eagle discusses insights from the DAPA-HF Trial concerning the initial decline in Estimated Glomerular Filtration Rate following the initiation of dapagliflozin in patients with heart failure and reduced ejection fraction, then looks at which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation. Finally, Dr. Eagle explores the use of high-intensity statin use among patients with atherosclerosis in the U.S.

Clinical Topics: Arrhythmias and Clinical EP, Cardiac Surgery, Congenital Heart Disease and Pediatric Cardiology, Dyslipidemia, Invasive Cardiovascular Angiography and Intervention, Valvular Heart Disease, Atherosclerotic Disease (CAD/PAD), Implantable Devices, SCD/Ventricular Arrhythmias, Aortic Surgery, Cardiac Surgery and Arrhythmias, Cardiac Surgery and CHD and Pediatrics, Cardiac Surgery and VHD, Congenital Heart Disease, CHD and Pediatrics and Arrhythmias, CHD and Pediatrics and Interventions, CHD and Pediatrics and Prevention, Nonstatins, Novel Agents, Statins, Interventions and Structural Heart Disease, Interventions and Vascular Medicine, Prevention

Keywords: EaglesEyeView, Calcium, Transcatheter Aortic Valve Replacement, Aortic Valve, Bicuspid Aortic Valve Disease, Bioprosthesis, Aortic Valve Stenosis, Heart Valve Prosthesis Implantation, Sodium-Glucose Transporter 2 Inhibitors, Stroke Volume, Glomerular Filtration Rate, Ventricular Function, Left, Out-of-Hospital Cardiac Arrest, Defibrillators, Cardiopulmonary Resuscitation, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cardiovascular Diseases, Atherosclerosis, Peripheral Arterial Disease

< Back to Listings